Athersys, Inc. (NASDAQ:ATHX) gained 11.64%, the stock was plummeting last week after the biotechnology company announced that its experimental stem-cell therapy to treat the inflammatory bowel disease ulcerative colitis did not show any benefits in patients in a mid-stage trial. Athersys, Inc. (NASDAQ:ATHX) shares after opening at $1.64 moved to $1.82 on last trade day and at the end of the day closed at $1.70 . Company price to sales ratio in past twelve months was calculated as 54.63 and price to cash ratio as 4.11. Athersys, Inc. (NASDAQ:ATHX) showed a positive weekly performance of 27.82%.
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) gained more than 3% on Monday amid strong buying and good volumes in the stock. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has been on a strong downward momentum in the last couple of trading sessions and has been on a downward trend since March. The stock has lost nearly 40% in the last two months, but seems to be gaining some upward momentum. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) shares advanced 3.96% in last trading session and ended the day on $28.64. NPSP return on equity ratio is recorded as -19.50% and its return on assets is -5.20%. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) yearly performance is 116.15%.
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Director Torsten Rasmussen sold 32,857 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $20.03, for a total transaction of $658,125.71. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares moved up 3.16% in last trading session and was closed at $20.21 while trading in range of $18.86 – $20.44 – ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) year to date (YTD) performance is -19.13%.
The Board of Directors of Intrexon Corporation (NYSE:XON) accepted the resignation of Thomas D. Reed from his position as director. Dr. Reed will continue to serve as Chief Science Officer of the Company. To fill the vacancy on the Board left by Dr. Reed’s resignation and upon recommendation of its Nominating and Governance Committee, the Board appointed James S. The Board has not named Mr. Turley to serve on any committees of the Board at this time. As a non-employee director of the Company, Mr. Turley will be eligible to participate in the Company’s compensation arrangements for non-employee directors, as described in the Company’s annual proxy statement. Intrexon Corp (NYSE:XON) weekly performance is -3.28%. On last trading day company shares ended up $18.00. Intrexon Corp (NYSE:XON) distance from 50-day simple moving average (SMA50) is -26.54%. Analysts mean target price for the company is $31.75.